RE: Great Summary28 Dec 2020 13:15
@13th - I am only going by what GB has posted. Even if there are no RNSs, the 'total' revenue should be reflected in the figures. For example - GB says
1. Most shareholders overlook that COVID19 accelerated the development of an already operational pathogen detection and identification system for #ModernWater equipment that already detected 2700+ virus, bacteria and toxins
2. A lot of the infrastructure already exists, over 3000 units installed, just needs to be retrofitted to add #AI and real-time identification of the target pathogen
3. You forgot that there is 30+ years and 60+ countries where #Microtox is a recognised incumbent water contamination Brand.
I am taking all of the above at face value. Yet, if the process(es) are so widespread and successful, *cumulatively* there ought to be more revenue coming in?
I continue to remain invested in this company - the Q is whether it is a case of 'Jam Tomorrow' for ever?